On this page
Alternative treatment strategies (ATS) implemented in Massangam Health District (HD) including test and treat with doxycycline and ivermectin mass drug administration (MDA) could only reach 20% of the nomadic population considered to be at higher risk of infection and reservoir for transmission.
As well as the implicit equity concerns with the exclusion of this group from both treatment strategies, there is a risk that they constitute a roaming reservoir of transmission and will impede elimination efforts. A recent qualitative assessment of the ATS in the Massangam health area (HA) revealed the barriers in reaching this hard-to-reach nomadic population.
The barriers included remote, dispersed and small settlements, high mobility, communication barriers, CDD-linked challenges, limited information on them, low awareness of mass drug administration and education/literacy rates.
This study trialled and evaluated a mobile outreach strategy with test and treat with doxycycline, to better serve the semi-nomadic population. In doing so, it explored the movement and turnover of the population and also determined the level (rate) of onchocerciasis infection in them.
Read the summary report (pdf)
Research_Summary_SSI_nomad_FINAL
Read the full report (pdf)
Sightsavers_Nomad report_ FINAL
Other resource
Project: Alternative intervention strategies for accelerating onchocerciasis elimination
Blog: Reaching nomadic communities during COVID-19
‘From the field’ article and video: Finding nomadic communities – our research in action